Ironwood Pharmaceuticals, Inc. , a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, presented new findings ...
An overview of the validation and qualification requirements introduced in the 2022 EU GMP Annex 1 revision, with a focus on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results